Article History
Received: 11 May 2022
Revised: 16 June 2022
Accepted: 16 June 2022
First Online: 25 June 2022
Competing interests
: UC was visiting Professor at Hoffmann La Roche who hold a license for anti-VEGF treatments which are commented on in this perspective. Professor UC no longer holds this position as her term has ceased. Dr BGA and Dr SF are employees of Hoffmann La Roche.
Free to read: This content has been made available to all.